The protein expression of NF-κB (used as an indicator of tumor cell proliferation and survival) following the combinatorial treatment was not significantly (p > 0.05) but by tendency reduced compared to its expression level in untreated tumors (9 and 28 days after the first tumor therapy, Figure 4). Here, NFKB1 is linked to neoplasm.